Clinical Trial

3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer

Study acronym: 3D-4K-ICG
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated June 24, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Patients with locally advanced gastric adenocarcinoma (CT2-4a N-/+ M0) were selected as study subjects to investigate the safety, efficacy, and feasibility of ICG near-infrared imaging tracing in 3D plus ultra high resolution laparoscopic gastrectomy with lymph node dissection for gastric cancer.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-30; most recent amendment 2024-06-20.
Status change: Not Yet Recruiting → Recruiting 2024-06-20
Trial Details
NCT Number NCT06161207
Lead Sponsor Fujian Medical University
Conditions Gastric Cancer, Surgery
Enrollment 702 participants
Start Date 2023-01-03
Primary Completion 2026-01-01 (estimated)
Study Completion 2029-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-06-24